From clinical proteomics to translatable therapeutic targets
Integrated proteomics and AI analytics can help connect disease biology, biomarker discovery and therapeutic target validation.
Disease biology is often hidden across heterogeneous clinical samples, dynamic protein expression and context-dependent cell states. Translational proteomics gives discovery teams a higher-resolution view of those changes.
Foreseen’s platform combines mass-spectrometry proteomics, multi-omics interpretation and AI-assisted prioritization to nominate targets with stronger biological relevance and clearer validation paths.
The goal is to move from signal to mechanism, then from mechanism to drug or diagnostic programs that can be tested through rigorous translational evidence.
Collaboration & media inquiries
For additional information about the platform, pipeline or partnership opportunities, submit an inquiry through the contact page.
Contact Foreseen